Picture of Akari Therapeutics logo

AKTX Akari Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Akari Therapeutics Files Prospectus Relates To Resale, By Selling Shareholders, Of Upto Total Of 642,753 ADS, Representing 1.3 Billion Ordinary Shares

Oct 20 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS: FILES PROSPECTUS RELATES TO RESALE, BY
SELLING SHAREHOLDERS, OF UPTO TOTAL OF 642,753 ADS, REPRESENTING
1.3 BILLION ORDINARY SHARES

Source text for Eikon:  ID: 
Further company coverage:  AKTX.O

Recent news on Akari Therapeutics

See all news